The global transplant diagnostic market is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research Inc. The rising demand for organ transplantation is primarily fueling the demand for transplant diagnostics.
Constant healthcare research and development efforts are resulting in the introduction of technically advanced treatments, such as stem cell therapy and organ transplants. As a result, the adoption of these highly-advanced organ transplantation techniques is creating the demand for transplant diagnostics as they reduce the risk of infections and minimize the chances of an immune response through pre-operative assessments including histocompatibility tests, such as Human Leukocyte Antigen (HLA) typing, which determines donor-receiver organ or tissue compatibility prior to organ transplants.
In addition, pertinent organizations are supporting research and development initiatives in the field of organ transplant through grants and funding. As a result, innovative and advanced diagnostic tools are frequently entering into the market. On the other hand, high cost of the diagnostic tests is one of the major factors hindering the growth of the market.
Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America and Europe together accounted for the largest market share in 2015. Developed economies and well-established healthcare infrastructure coupled with the presence of a highly developed research infrastructure are accelerating the adoption of organ and tissue transplant therapies in Europe and North America. As a consequence, the demand for transplant diagnostics is high in North America and Europe.
Wide adoption of HLA typing owing to its ability to determine organ compatibility between the donor and the receiver preceding organ transplants and to predict potential perioperative immunological complications is driving the growth of the molecular assay market in North America and Europe.
Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the booming medical tourism in countries, such as India. Availability of advanced healthcare infrastructure and skilled professionals at alower costare anticipated to attract patients worldwide to this region for transplant procedures.
In addition, the presence of highly advanced healthcare infrastructure and the ongoing government initiatives to improve healthcare facilities in the country are collectively anticipated to boost the market growth in Japan during the forecast period. As a result, the Asia Pacific market is anticipated to reach USD 216.6 million in 2024.
In depth
research report on adhesives and sealants market
http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market
http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market
Further key findings from the study suggest:
·
The PCR-based
molecular assay captured the largest share of the overall market in 2015. The
large market share was mainly attributed to the extensive adoption of the PCR
technique in HLA typing.
·
The
sequencing-based typing segment is anticipated to witness significant growth
rate from 2016 to 2024. The escalation in the adoption of next generation
sequencing (NGS) is the major factor expected to drive the growth of this
segment during the forecast period.
·
The
integration of sequencing with serological typing enhances diagnostic outcomes
and, hence is expected to augment the growth of the sequencing segment during
the forecast period
·
The reagents
and consumables segment accounted for the largest market share in 2015. This
large share is mainly attributed to the repeat purchase of these products.
·
North America
captured the largest market share of around 38% in 2015 and is expected to
maintain its dominance throughout the forecast period. Well-established
research infrastructure, the increasing healthcare expenditure, high adoption
rate ofthe advanced diagnostic techniques, and the growing R&D activities
are some of the factors supporting the growth of the market in the region.
·
Asia Pacific
is expected to witness significant growth during the forecast period owing to
the expanding research opportunities, the increasing health care expenditure,
and the rising awareness of organ donation in the region.
·
The booming
medical tourism industry offers further growth opportunities for the market in
Asia Pacific
·
Some major
players in this market include Thermo Fisher Scientific, Inc., Illumina, Inc.,
F.Hoffmann La-Roche AG. Abbott Laboratories, Inc.,Qiagen N.V., Immucor
Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Affymetrix,
Inc., and Omixon Ltd.
Grand View Research has segmented the
Transplant Diagnostic Market on the basis of technology, product, and geography.
Transplant
Diagnostic Market by Technology, 2013 - 2024 (USD Million)
·
Molecular
o
PCR-Based
Molecular Assays
o
Sequencing-Based
Molecular Assays
·
Non-Molecular
Assays
o
Serological
Assays
o
Mixed
Lymphocyte Culture (MLC) Assays
Transplant
Diagnostic Market by Product, 2013 - 2024 (USD Million)
·
Reagents and
Consumables
·
Instruments
·
Software and
Services
Transplant
Diagnostics Market, by Region, 2013- 2024 (USD Million)
·
North America
o
U.S.
Transplant Diagnostics Market by Product Type
o
Canada
Transplant Diagnostics Market by Product Type
o
U.S.Transplant
Diagnostics Market by Technology Type
o
Canada
Transplant Diagnostics Market by Technology
·
Europe
o
Germany
Transplant Diagnostics Market by Product Type
o
France
Transplant Diagnostics Market by Product Type
o
Germany
Transplant Diagnostics Market by Technology
o
France
Transplant Diagnostics Market by Technology
·
Asia Pacific
o
China
Transplant Diagnostics Market by Product Type
o
India
Transplant Diagnostics Market by Product Type
o
China
Transplant Diagnostics Market by Technology
o
India
Transplant Diagnostics Market by Technology
·
Latin America
o
Brazil
Transplant Diagnostics Market by Product Type
o
Mexico
Transplant Diagnostics Market by Product Type
o
Brazil
Transplant Diagnostics Market by Technology
o
Mexico
Transplant Diagnostics Marketby Technology
·
MEA
o
South Africa
Transplant Diagnostics Market by Product Type
o
South Africa
Transplant Diagnostics Market by Technology
Browse more research reports of this
category:
About
Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
For more market
analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment